Supercar maker Lamborghini has announced that it is collaborating with the Houston Methodist Research Institute, to share knowledge in the study of carbon fibre composite materials for medical devices. The ongoing research project is focused on a biocompatibility study of composite materials to be used mainly in prosthetic implants, but also in subcutaneous devices. The aim is to identify new materials that are lighter, better tolerated by the human body, and more resistant over time than those currently used in the medical field.
Mauro Ferrari president and CEO of the Houston Methodist Research Institute, was welcomed in Sant’Agata Bolognese by Stefano Domenicali, chairman and chief executive officer of Lamborghini. Mauro Ferrari is an Italian scientist engaged mainly in nanotechnology research and in the field of applied bioengineering in medicine. Lamborghini is an active player in the research and production of carbon fibre composite materials, and the Advanced Composite Lightweight Structures Department of Research & Development provides its experience, not only in the automotive field, but also in the biomedical sector.
In addition to Houston Methodist Research Institute, Lamborghini collaborates in Italy, on this and other research projects, with the Occupational Medicine Unit of Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic, the Neurosurgery of IRCCS Institute of Neurological Sciences of Bologna, the Neurosurgery Humanitas University Rozzano-Milano, the CNR Institute of Neuroscience and IRCSS Rizzoli Orthopedic Institute of Bologna.
How Lamborghini is accelerating medical device innovation